# Arda Therapeutics, Inc. — Form D

Arda Therapeutics, Inc. of San Carlos, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-10-02. The offering totals $43.4M, of which $43.3M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-10-02
- Form: D
- Accession: 0001903317-24-000002
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $43.4M
- Amount sold: $43.3M
- Remaining: $135K
- Investors: 17
- Date of first sale: 2024-09-16
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-525632

## Issuer

- Name: Arda Therapeutics, Inc.
- CIK: 0001903317
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 930 Brittan Ave, San Carlos, CA, 94070
- Phone: (650) 804-8953

## Officers, directors & promoters (3)

| Name | Role | Location |
| --- | --- | --- |
| Vineeta Agarwala | Director | Menlo Park, CA |
| Adam Freund | Director | San Carlos, CA |
| Adam Freund | Executive Officer | San Carlos, CA |

## Other filings by this issuer (1)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2022-01-14](https://search.stillhousedata.com/formd/0001903317-22-000001) | D | $8.5M | $7.5M |

## More

- [CIK 1903317 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1903317&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001903317-24-000002.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.